The role of stress-response systems for the pathogenesis and progression of MS

Trends in Immunology

Volumn 26, Issue 12, 2005, Pages 644-652

  Gold, Stefan M ^a   Mohr, David C ^b   Huitinga, Inge ^c   Flachenecker, Peter ^d   Sternberg, Esther M ^e   Heesen, Christoph ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^d Neurologisches Rehabilitationszentrum Quellenhof ^*  (Germany)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR;

ADRENERGIC SYSTEM; AUTOIMMUNE DISEASE; AUTONOMIC NERVOUS SYSTEM; DEMYELINATING DISEASE; DISEASE COURSE; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNE SYSTEM; INFLAMMATION; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION; STRESS; T LYMPHOCYTE;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; MULTIPLE SCLEROSIS; STRESS;

EID: 27744500299     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.09.010     Document Type: Review

References (70)

1. Charcot, J.M. (1877) Lectures on Diseases on the Nervous System (G Sigerson, Trans.), New Sydenham Society
2. D.C. Mohr Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis BMJ 328 2004 731 735
3. G. Filippini Interferons in relapsing remitting multiple sclerosis: a systematic review Lancet 361 2003 545 552
4. D.S. Goodin The relationship of MS to physical trauma and psychological stress: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology Neurology 52 1999 1737 1745
5. D.C. Mohr Psychological stress and the subsequent appearance of new brain MRI lesions in MS Neurology 55 2000 55 61
6. J.I. Webster Neuroendocrine regulation of immunity Annu. Rev. Immunol. 20 2002 125 163
7. M.S. Harbuz Changes in hypothalamic corticotrophin-releasing factor and anterior pituitary pro-opiomelanocortin mRNA during the course of experimental allergic encephalomyelitis J. Neuroimmunol. 45 1993 127 132
8. A.C. Griffin Suppression of experimental autoimmune encephalomyelitis by restraint stress: sex differences J. Neuroimmunol. 44 1993 103 116
9. A. Del Rey Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1 Am. J. Physiol. 275 1998 R1146 R1151
10. D. Mason The role of the neuroendocrine system in determining genetic susceptibility to experimental allergic encephalomyelitis in the rat Immunology 70 1990 1 5
11. I. MacPhee Spontaneous recovery from rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids J. Exp. Med. 169 1989 431 445
12. A. Stefferl Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone Endocrinology 142 2001 3616 3624
13. D. Michelson Multiple sclerosis is associated with alterations in hypothalamic-pituitary-axis function J. Clin. Endocrinol. Metab. 79 1994 848 853
14. A.T. Reder Adrenal size is increased in multiple sclerosis Arch. Neurol. 51 1994 151 154
15. J.S. Purba Increased number of corticotropin releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of patients with multiple sclerosis Neuroendocrinology 62 1995 62 70
16. Z.A. Erkut Increased activity of hypothalamic cortcotropin-releasing hormone neurons in multiple sclerosis J. Neuroimmunol. 62 1995 27 33
17. A.T. Reder Dexamethasone suppression test abnormalities in multiple sclerosis: relation to ACTH therapy Neurology 37 1987 849 853
18. T. Wei, and S.L. Lightman The neuroendocrine axis in patients with multiple sclerosis Brain 120 1997 1067 1076
19. P. Limone Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-β treatment Acta Neurol. Scand. 105 2002 372 377
20. K. Fassbender Mood disorders and dysfunction of the hypothalamic- pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation Arch. Neurol. 55 1998 66 72
21. E.M. Schumann Activity of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: correlations with gadolinium-enhancing lesions and ventricular volume Ann. Neurol. 51 2002 763 767
22. F. Then Bergh Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course in multiple sclerosis Neurology 53 1999 772 777
23. C. Heesen Cognitive impairment correlates with hypothalamo-pituitary- adrenal axis dysregulation in multiple sclerosis Psychoneuroendocrinology 27 2002 505 517
24. Heesen, C. et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behavior? J. Neurol. Neurosurg. Psychiatry (in press)
25. S.M. Gold Hypothalamo-pituitary-adrenal axis activity predicts disease progression in multiple sclerosis J. Neuroimmunol. 165 2005 186 191
26. R.H. DeRijk Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production J. Neuroimmunol. 151 2004 180 188
27. L.M. van Winsen Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis J. Clin. Endocrinol. Metab. 90 2005 734 740
28. F. Then Bergh Binding characteristics of the glucocorticoid receptor in peripheral blood lymphocytes in multiple sclerosis J. Neurol. 246 1999 292 298
29. Z.A. Erkut Cortisol is increased in postmortem cerebrospinal fluid of multiple sclerosis patients: relationship with cytokines and sepsis Mult. Scler. 8 2002 229 236
30. I. Huitinga The hypothalamo-pituitary-adrenal axis in multiple sclerosis Ann. N. Y. Acad. Sci. 992 2003 118 128
31. C. Bjartmar, and B.D. Trapp Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences Curr. Opin. Neurol. 14 2001 271 288
32. I. Huitinga Impaired hypothalamus-pituitary-adrenal axis activity and more severe multiple sclerosis with hypothalamic lesions Ann. Neurol. 55 2004 37 45
33. E. Chelmicka-Schorr Chemical sympathectomy augments the severity of experimental allergic encephalomyelitis J. Neuroimmunol. 17 1988 347 350
34. E. Chelmicka-Schorr Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis J. Neuroimmunol. 37 1992 99 103
35. C.F. Brosnan Prazosin, an α1-adrenergic receptor antagonist, suppresses experimental autoimmune encephalomyelitis in the Lewis rat Proc. Natl. Acad. Sci. U. S. A. 82 1985 5915 5919
36. S.R. White Prazosin suppresses development of axonal damage in rats inoculated for experimental allergic encephalomyelitis J. Neuroimmunol. 39 1992 211 218
37. E. Chelmicka-Schorr The β-adrenergic agonist isoproterenol suppresses experimental allergic encephalomyelitis in Lewis rats J. Neuroimmunol. 25 1989 203 207
38. K. Wiegmann β-adrenergic agonists suppress chronic/relapsing experimental allergic encephalomyelitis (CREAE) in Lewis rats J. Neuroimmunol. 56 1995 201 206
39. V. Sanders, and R.H. Straub Norepinephrine, the β-adrenergic receptor, and immunity Brain Behav. Immun. 16 2002 290 332
40. J. Szelenyi Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-α production by α2- and β-adrenoceptors in mice J. Neuroimmunol. 103 2000 34 40
41. M. Frontoni, and F. Giubilei Autonomic dysfunction in MS Int. MS J. 6 1999 79 87
42. J.W. Karaszewski Increased high affinity β-adrenergic receptor densities and cyclic AMP responses of CD8 cells in multiple sclerosis J. Neuroimmunol. 43 1993 1 7
43. P. Lachenecker Autonomic dysfunction in multiple sclerosis is related to disease activity and progression of disability Mult. Scler. 7 2001 327 334
44. C. Rajda Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients J. Neuroimmunol. 124 2002 93 100
45. M. Consentino Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis J. Neuroimmunol. 133 2002 233 240
46. K.J. Tracey The inflammatory reflex Nature 420 2002 853 859
47. C.J. Czura, and K.J. Tracey Autonomic neural regulation of immunity J. Intern. Med. 257 2005 156 166
48. J.W. Karaszewski Sympathetic skin responses are decreased and lymphocyte β-adrenergic receptors are increased in progressive multiple sclerosis Ann. Neurol. 27 1990 366 372
49. Y. Zoukos β-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1 Ann. Neurol. 31 1992 657 662
50. - suppressor cell Ann. Neurol. 30 1991 42 47
51. Y. Zoukos Increased expression of high affinity IL-2 receptors and β-adrenoceptors on peripheral blood mononuclear cells is associated with clinical and MRI activity in multiple sclerosis Brain 117 1994 307 315
52. Y. Zoukos Expression of β2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study J. Neurol. Neurosurg. Psychiatry 74 2003 197 202
53. C. Heesen Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNγ) release in multiple sclerosis patients and controls J. Neuroimmunol. 132 2002 189 195
54. K. Haerter In vitro adrenergic modulation of cellular immune functions in experimental autoimmune encephalomyelitis J. Neuroimmunol. 146 2004 126 132
55. M. Giorelli Post-receptorial mechanisms underlie functional dysregulation of β2-adrenergic receptors in lymphocytes from multiple sclerosis patients J. Neuroimmunol. 155 2004 143 149
56. A. Vroon G protein-coupled receptor kinase 2 in multiple sclerosis and experimental autoimmune encephalomyelitis J. Immunol. 174 2005 4400 4406
57. B. Hemmer New concepts in the immunopathogenesis of multiple sclerosis Nat. Rev. Neurosci. 3 2002 291 301
58. 2-adrenergic receptors Neurology 53 1999 1628 1633
59. J. De Keyser Astrocytic β2-adrenergic receptors and multiple sclerosis Neurobiol. Dis. 15 2004 331 339
60. K. Makhlouf Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis J. Neuroimmunol. 117 2001 156 165
61. K. Makhlouf Potential of β2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol) CNS Drugs 16 2002 1 8
62. S. Bedoui More sympathy for autoimmunity with neuropeptide Y? Trends Immunol. 25 2004 508 512
63. M. Cutolo Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis Ann. N. Y. Acad. Sci. 992 2003 107 117
64. C.C. Mok, and C.S. Lau Pathogenesis of systemic lupus erythematosus J. Clin. Pathol. 56 2003 481 490
65. M. Harbuz Hypothalamo-pituitary-adrenal axis and chronic immune activation Ann. N. Y. Acad. Sci. 992 2003 99 106
66. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu. Rev. Immunol. 23 2005 683 747
67. H. Lassmann Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy Trends Mol. Med. 7 2001 115 121
68. M. Filippi Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group J. Magn. Reson. Imaging 21 2005 669 675
69. C.N. Metz, and K.J. Tracey It takes nerve to dampen inflammation Nat. Immunol. 6 2005 756 757
70. G.P. Chrousos, and P.W. Gold The concepts of stress and stress systems disorders. Overview of physical and behavioral homeostasis JAMA 267 1992 1244 1252